HOME >> BIOLOGY >> NEWS
Science highlights of AAN Annual Meeting in Honolulu March 29 April 5

nd they represent an attractive therapeutic target.

Two studies examined the role of bacterial infection with Chlamydia pneumoniae in worsening of MS symptoms. In one of these, researchers from the United States, Canada and the Netherlands found that subclinical infection did not cause MS, but it did increase the risk of exacerbations in the relapsing-remitting form of MS. These results suggest that a trial of antibiotic treatment of such infections is warranted because it may help mitigate disease exacerbation in some patients.

Epilepsy For many patients with epilepsy, surgery that removes pat of the temporal lobe (a portion of the brain above and in front of the ear) effectively reduces the number and severity of seizures. Researchers from Rush Medical College, Chicago, showed that while 25 percent of patients develop post-surgical psychiatric complications, including depression and mania, these respond very well to drug therapy, and were not associated with poorer seizure reduction or type of temporal lobe epilepsy.

The success of epilepsy surgery was examined in children under three years old who had delayed mental development and were not adequately treated by antiseizure medicines. Surgery reduced seizures and the number of antiseizure drugs required, and most infants improved in their rate of mental development, according to researchers from the Cleveland Clinic Foundation.

Investigators at Wayne State University showed that patients with temporal lobe epilepsy who refused surgery had progressive atrophy of the hippocampus if seizures continued. In patients who became seizure-free from medical treatment, the loss of hippocampal tissue was arrested. This is further evidence that temporal lobe epilepsy is a progressive disorder that requires aggressive treatment, including surgery if indicated, to eliminate seizures.

Alzheimers disease The frank dementia of Alzheimers disease is often preceded by a long
'"/>

Contact: Marilee Reu
mreu@aan.com
651-695-2789
American Academy of Neurology
14-Apr-2003


Page: 1 2 3 4

Related biology news :

1. A long-necked sea predator from China described in Science
2. Brown ecologist garners major National Science Foundation grant
3. Popular Science announces Third Annual Brilliant 10
4. Winner of 2004 EMBO Science Writing Prize announced
5. Study in Science reveals recreational fishing takes big bite of ocean catch
6. New paper in Science introduces revolutionary new paradigm for fishery management
7. Articles on forest fire risks published in BioScience
8. Ralph J. Cicerone nominated to be next National Academy of Sciences president
9. Canine word-learning research published in Science
10. Articles on remote sensing in ecology published in BioScience
11. Fostering Diversity in the Sciences Symposium

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Science highlights AAN Annual Meeting Honolulu March April

(Date:6/19/2013)... 2012, the European Medicines Agency (EMA) approved the ... ever gene therapy for clinical use in the ... developed AAV-LPL S447X for the treatment of a ... (LPLD) which affects approximately one or two out ... life-threatening inflammations of the pancreas. Afflicted individuals carry ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
(Date:6/18/2013)... June 18, 2013 Joshua Obar, Ph.D., Department ... been honored with a 2013 ICAAC Young Investigator Award ... of immunological memory responses to infection. , Obar ... in 2001 and went on to complete his Ph.D. ... He performed his Ph.D. thesis research in Edward ...
Breaking Biology News(10 mins):No danger of cancer through gene therapy virus 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2The American Society for Microbiology honors Joshua Obar 2
(Date:6/19/2013)... Calif. , June 19, 2013  Continuing its ... myocardial infarction (MI), Beckman Coulter , Inc. announces ... of its new Access AccuTnI+3 troponin I assay for ... "Clinicians have depended on Beckman Coulter,s ... new AccuTnI+3 assay has the proven performance to continue ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Today DuPont ... young people to become leaders in the greatest challenge ... billion people in 2050. Borel spoke at the ... Conference in Atlanta, about urgent need for students to ... are local, science-based, sustainable and reached in collaboration with ...
(Date:6/19/2013)... 2013 BioConvergence team members Curtis ... at 2013’s BioLogistics Summit in San Francisco earlier ... Cold Chain IQ and IQPC, addressed the increasingly ... in part, attributed to current trends of globalization, ... these trends is an increase in movement, which ...
(Date:6/19/2013)... June 18, 2013 A new look ... costs and other trends will highlight technical sessions at ... this fall. In its 33rd year, the three-day event ... exhibition of key suppliers, approximately 100 technical presentations and ... the international society for optics and photonics , the ...
Breaking Biology Technology:Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2BioConvergence® Presents at BioLogistics Summit on Risk Matrix for Biosamples during Shipment 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 2‘Big Glass’ and Visions for the Future are on the Program for SPIE Photomask Technology 3
Cached News: